Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-31

Clinical Trial Update: Oxytocin and CBSST for People With Schizophrenia [NA]

View source ↗

Summary

Clinical trial update for oxytocin and CBSST in schizophrenia and schizoaffective disorder has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CBSST
  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2017-10-31